APLS vs INTC · rev $781.4M vs rev $29.70B
Apellis Pharmaceuticals Inc (APLS) versus Intel Corporation (INTC) — a side-by-side from cached financials, not a winner call.
Apellis Pharmaceuticals Inc (APLS) is a biotechnology company listed on US.
Intel Corporation (INTC) is a semiconductors company listed on US. It is led by Pat Gelsinger.
Latest reported APLS revenue for 2024-12-31 was $781.4M. Net income was -$197.9M. Revenue was up 97.0% from 2023-12-31 to 2024-12-31. APLS currently screens at market cap $2.29B.
Latest reported INTC revenue for 2026-06-27 was $29.70B. Net income was -$14.76B. INTC currently screens at market cap $498.43B.
APLS currently screens at market cap $2.29B. INTC currently screens at market cap $498.43B.
Not investment advice. Open the APLS and INTC stock pages for the full models.
Not investment advice.